Stocks and Investing Stocks and Investing
Thu, February 15, 2024

Andy Chen Initiated (ALNY) at Hold on, Feb 15th, 2024


Published on 2024-10-28 08:59:16 - WOPRAI, Andy Chen
  Print publication without navigation


Andy Chen of Wolfe Research, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold on, Feb 15th, 2024.

Andy has made no other calls on ALNY in the last 4 months.



There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 3 agree with Andy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $176 on, Tuesday, February 13th, 2024
  • Jessica Fung of "JP Morgan" Maintained at Hold with Increased Target to $170 on, Thursday, February 1st, 2024
  • Tiago Fauth of "Wells Fargo" Initiated at Hold and Held Target at $171 on, Friday, December 8th, 2023


These are the ratings of the 3 analyists that currently disagree with Andy


  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $235 on, Wednesday, February 14th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Friday, December 15th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $217 on, Thursday, December 14th, 2023
Contributing Sources